Your browser doesn't support javascript.
loading
Combined Deep Brain Stimulation of Subthalamic Nucleus and Ventral Intermediate Thalamic Nucleus in Tremor-Dominant Parkinson's Disease Using a Parietal Approach.
Neudorfer, Clemens; Hinzke, Markus; Hunsche, Stefan; El Majdoub, Faycal; Lozano, Andres; Maarouf, Mohammad.
Affiliation
  • Neudorfer C; Department of Stereotaxy and Functional Neurosurgery, Cologne-Merheim Medical Center (CMMC), University of Witten/Herdecke, Cologne, Germany.
  • Hinzke M; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Hunsche S; Department of Neurology, Cologne-Merheim Medical Center (CMMC), University of Witten/Herdecke, Cologne, Germany.
  • El Majdoub F; Department of Stereotaxy and Functional Neurosurgery, Cologne-Merheim Medical Center (CMMC), University of Witten/Herdecke, Cologne, Germany.
  • Lozano A; Department of Stereotaxy and Functional Neurosurgery, Cologne-Merheim Medical Center (CMMC), University of Witten/Herdecke, Cologne, Germany.
  • Maarouf M; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Neuromodulation ; 22(4): 493-502, 2019 Jun.
Article in En | MEDLINE | ID: mdl-30889314
ABSTRACT

OBJECTIVES:

Despite its efficacy in tremor-suppression, the ventral intermediate thalamic (VIM) nucleus has largely been neglected in deep brain stimulation (DBS) for tremor-dominant Parkinson's disease (tdPD). The employment of a parietal approach, however, allows stimulation of VIM and subthalamic nucleus (STN) using one trajectory only and thus constitutes a promising alternative to existing strategies. In the present study, we investigate safety and efficacy of combined lead implantation and stimulation of STN and VIM using a parietal approach. MATERIALS AND

METHODS:

Retrospective analysis of five patients with tdPD was performed who underwent DBS using a parietal approach. Changes in symptom severity, disease-specific health-related quality of life and l-dopa equivalent doses (LED) were evaluated over a total time course of 12 months.

RESULTS:

DBS within both targets yielded significant improvement of parkinsonian symptoms (median 40.0%, p = 0.04) in the first 6 months of continuous stimulation and remained stable thereafter (median improvement at 12 months 43.2%, p = 0.07). Sustained improvement of tremor (median at 6 months 100.0%, p = 0.04; median at 12 months 83.3%, p = 0.04) and quality of life scores (median at 6 months 29.8%, p = 0.04; median at 12 months 32.6%, p = 0.04) was noted throughout the follow-up period. No significant change of LEDs was observed by the end of follow-up (median decrease 2.2%, p = 0.89).

CONCLUSIONS:

Simultaneous DBS of VIM and STN using one trajectory is safe, yielding good control of parkinsonian tremors. Further studies, however, are necessary to determine whether a parietal trajectory affords better control over tremor symptoms than established strategies and hence justifies the potential risks associated with the alternative approach.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Parietal Lobe / Parkinson Disease / Tremor / Subthalamic Nucleus / Ventral Thalamic Nuclei / Deep Brain Stimulation Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Neuromodulation Year: 2019 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: Parietal Lobe / Parkinson Disease / Tremor / Subthalamic Nucleus / Ventral Thalamic Nuclei / Deep Brain Stimulation Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Neuromodulation Year: 2019 Type: Article Affiliation country: Germany